The long term objective of the proposed research is to elucidate the functions and regulation of the tissues of the blood-brain barrier (microvasculature) and blood-CSF barrier (choroid plexus). There are three specific objectives for the current research: 1) To determine whether brain-barrier tissues may serve as end organs for atriopeptins (AP's), recently identified salt and water regulatory factors secreted from the heart; 2) To determine whether the choroid plexus has an immunological function for the brain; 3) To determine and characterize the beta-adrenergic regulation of neutral amino acid uptake into cerebral microvessels. Preliminary data from this laboratory support the existence of all three of the above functions. The research will utilize a combination of biochemical and physiological methods, including receptor regulation of cyclic nucleotides, cell separation and isolation techniques, determinations of hormone effects on CSF production via ventricular-cisternal perfusion, measurements of antigen-specific cytotoxicity and lymphocyte activation by barrier tissues, and measurements of isotope uptake and efflux in isolated barrier tissue cells. The three specific objectives have clinical implications for: 1) control of cerebral edema and hydrocephalus; 2) initiation of immunological responses to CNS bacterial and viral infections, and surveillance of tumor cells in CSF; and 3) brain nutrition and delivery of drugs for treatment of certain CNS diseases (e.g., Parkinsonism).

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS016356-07
Application #
3396842
Study Section
Neurology A Study Section (NEUA)
Project Start
1980-07-01
Project End
1989-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
7
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Wijdicks, E F; Ropper, A H; Hunnicutt, E J et al. (1991) Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage. Stroke 22:1519-24
Wijdicks, E F; Ropper, A H; Nathanson, J A (1990) Atrial natriuretic factor and blood pressure fluctuations in Guillain-Barre syndrome. Ann Neurol 27:337-8
Gabriel, S M; Milbury, C M; Alexander, S M et al. (1989) Iso stimulation of GH and cAMP: comparison of beta-adrenergic- to GRF-stimulated GH release and cAMP accumulation in monolayer cultures of anterior pituitary cells in vitro. Neuroendocrinology 50:170-6
Nathanson, J A; Chun, L L (1989) Immunological function of the blood-cerebrospinal fluid barrier. Proc Natl Acad Sci U S A 86:1684-8
Nathanson, J A; Hunnicutt, E J (1988) Selective beta 2-adrenoceptor antagonists: derivatives of ICI 118,551 and a binary aryloxypropanolamine. J Pharm Pharmacol 40:803-5
Tapia-Arancibia, L; Pares-Herbute, N; Astier, H et al. (1988) Adenylate cyclase activation is not sufficient to stimulate somatostatin release from dispersed cerebral cortical and diencephalic cells in glia-free cultures. Brain Res 450:101-10
Gabriel, S M; Milbury, C M; Nathanson, J A et al. (1988) Galanin stimulates rat pituitary growth hormone secretion in vitro. Life Sci 42:1981-6
Nathanson, J A (1988) Direct application of a guanylate cyclase activator lowers intraocular pressure. Eur J Pharmacol 147:155-6
Nathanson, J A (1988) Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process. J Pharmacol Exp Ther 245:94-101
Steardo, L; Nathanson, J A (1987) Brain barrier tissues: end organs for atriopeptins. Science 235:470-3

Showing the most recent 10 out of 11 publications